Intrinsic Value of S&P & Nasdaq Contact Us

Molina Healthcare, Inc. MOH NYSE

NYSE • Healthcare • Medical - Healthcare Plans • US • USD

SharesGrow Score
59/100
2/7 Pass
SharesGrow Intrinsic Value
$1,104.47
+648.1%
Analyst Price Target
$175.64
+19%

Molina Healthcare, Inc. (MOH) is a Medical - Healthcare Plans company in the Healthcare sector, currently trading at $147.64. It has a SharesGrow Score of 59/100, indicating a above average investment profile with 2 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of MOH = $1,104.47 (+648.1% from the current price, the stock appears undervalued). Analyst consensus target is MOH = $176 (+19% upside).

Valuation: MOH trades at a trailing Price-to-Earnings (P/E) of 15.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.24.

Financials: revenue is $45.4B, +12.5%/yr average growth. Net income is $472M, growing at -4.7%/yr. Net profit margin is 1% (thin). Gross margin is 9% (-3.3 pp trend).

Balance sheet: total debt is $4.0B against $4.1B equity (Debt-to-Equity (D/E) ratio 0.97, moderate). Current ratio is 1.69 (strong liquidity). Debt-to-assets is 25.4%. Total assets: $15.6B.

Analyst outlook: 17 / 38 analysts rate MOH as buy (45%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 88/100 (Pass), Growth 48/100 (Partial), Past 100/100 (Pass), Health 67/100 (Partial), Moat 34/100 (Fail), Future 46/100 (Partial), Income 30/100 (Fail).

$175.64
▲ 18.97% Upside
Average Price Target
Based on 38 Wall Street analysts offering 12-month price targets for Molina Healthcare, Inc., the average price target is $175.64, with a high forecast of $310.00, and a low forecast of $124.00.
Highest Price Target
$310.00
Average Price Target
$175.64
Lowest Price Target
$124.00

MOH SharesGrow Score Overview

59/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 88/100
Valuation — P/E, PEG, Forward PEG
GROWTH 48/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 34/100
Gross margin is + market cap
FUTURE 46/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MOH

VALUE Pass
88/100
MOH trades at a trailing Price-to-Earnings (P/E) of 15.7 (S&P 500 average ~25). Forward PEG 0.24 — Peter Lynch undervalued (≤1.0). Analyst consensus target is $176, implying +19.2% from the current price $148. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
48/100
MOH: +12.5%/yr revenue is, -4.7%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
MOH: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet MOH: Debt-to-Equity (D/E) ratio 0.97 (moderate), Current ratio is 1.69 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Fail
34/100
MOH: Gross margin is 9% (-3.3 pp trend), $8B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 34/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
46/100
Analyst outlook: 17 / 38 analysts rate MOH as buy (45%). Analyst consensus target is $176 (+19.2% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
30/100
MOH: Net profit margin is 1%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range121.06-359.97
Volume507.74K
Avg Volume (30D)1.88M
Market Cap$7.69B
Beta (1Y)0.55
Share Statistics
EPS (TTM)8.93
Shares Outstanding$50.79M
IPO Date2003-07-02
Employees18,000
CEOJoseph Michael Zubretsky
Financial Highlights & Ratios
Revenue (TTM)$45.43B
Gross Profit$4.08B
EBITDA$976M
Net Income$472M
Operating Income$781M
Total Cash$4.25B
Total Debt$3.95B
Net Debt$-298M
Total Assets$15.56B
Price / Earnings (P/E)16.5
Price / Sales (P/S)0.17
Analyst Forecast
1Y Price Target$158.00
Target High$310.00
Target Low$124.00
Upside+7.0%
Rating ConsensusBuy
Analysts Covering38
Buy 45% Hold 39% Sell 16%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS60855R1005

Price Chart

MOH
Molina Healthcare, Inc.  ·  NYSE
Healthcare • Medical - Healthcare Plans
121.06 52WK RANGE 359.97
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message